RECENT ADVANCES IN TARGETING THE ANDROGEN RECEPTOR WITH PROTACS
Author:
Affiliation:
1. Departments of Internal Medicine, Pharmacology, and Medicinal Chemistry, University of Michigan
Publisher
MEDI, Inc. Published by American Chemical Society.
Link
https://pubs.acs.org/doi/pdf/10.1021/mc-2022-vol57.ch12
Reference69 articles.
1. Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications
2. Androgen receptor signaling in prostate cancer development and progression
3. Androgen Receptor in Breast Cancer—Clinical and Preclinical Research Insights
4. Role of the Androgen-Androgen Receptor Axis in the Treatment Resistance of Advanced Prostate Cancer: From Androgen-Dependent to Castration Resistant and Further
5. Androgen Receptor as a Driver of Therapeutic Resistance in Advanced Prostate Cancer
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Discovery of a Series of Orally Bioavailable Androgen Receptor Degraders for the Treatment of Prostate Cancer;Journal of Medicinal Chemistry;2024-07-11
2. Discovery of ARD-1676 as a Highly Potent and Orally Efficacious AR PROTAC Degrader with a Broad Activity against AR Mutants for the Treatment of AR + Human Prostate Cancer;Journal of Medicinal Chemistry;2023-09-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3